Loading…

P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA

Saved in:

Bibliographic Details
Published in:	HemaSphere 2022-06, Vol.6 (Suppl), p.1154-1155
Main Authors:	Frigault, M., Sher, S., Ravikrishnan, J., Izumi, R., Ware, J., Wong, H., Johnson, A., Stelte‐Ludwig, B., Byrd, J., Sampath, D., Rogers, K., Woyach, J., Lapalombella, R., Hamdy, A.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!